Heart Inflammation and Mental Stress Study
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 28, 2018 | ||
首次发布日期e ICMJE | October 3, 2018 | ||
最后更新发布日期 | October 3, 2018 | ||
预计研究开始日期 ICMJE | November 2018 | ||
预计主要完成日期 | February 2023 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Change in heart rate variability[ Time Frame: Baseline, pre-intervention and up to 60 minutes post-intervention ] Heart rate variability will be measured using a standard electrocardiogram to detect variability in R -to-R intervals. |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Heart Inflammation and Mental Stress Study | ||
正式标题 ICMJE | Heart Inflammation and Mental Stress Study | ||
简要概况 | The main objectives of the study are to assess (1) patterns of brain activity/connectivity that confers greater cardio-autonomic/emotion regulation, (e.g., heart rate variability, blood pressure reactivity, inflammatory-immune activation, etc.), during rest, mental stress, and anger-related distress, (2) whether changes in breathing pace mitigate task-based effects on cardio-autonomic-immune regulation, and (3) whether these patterns vary as a function of HIV or pre-hypertensive (HTN) status-related changes to the brain structures underlying cardioautonomic and emotion regulation. |
||
详细说明 | |||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: 盲法: Interventional 盲法描述: 主要目的: Basic Science |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Not yet recruiting | ||
预计入组 ICMJE |
144 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | February 2023 | ||
预计主要完成日期 | February 2023 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion criteria: 1. pre-hypertension screening. 2. HIV-antibody testing. Exclusion criteria: 1. current use of anti-lipid, antihypertensive, or heart rate altering medications; 2. current or lifetime history of cardiovascular disease diagnosis or treatment including pulmonary stenosis, heart valve abnormalities and hypertension; 3. current or lifetime diagnoses of cancer, kidney/liver disease, hypertension, Type 1 or Type 2 diabetes; 4. history of trauma, cerebral infarction or hemorrhage; 5. current diagnosis and/or treatment for hypertension; 6. severe cognitive impairment; 7. current treatment or diagnosis of psychiatric illness; 8. metal implants or debris within the body; or pregnancy; 9. body mass index > 35; 10. use of hormone replacement therapy; and current smoker. | ||
性别 |
|
||
年龄 | 最小年龄:21 Years ,最大年龄:65 Years | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | United States | ||
管理信息 | 数据检测委员会 | Yes | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Roger McIntosh,University of Miami | ||
研究赞助商 ICMJE | University of Miami | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | University of Miami | ||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |